AstraZeneca makes a big RNA play, teaming up with VaxEquityAstraZeneca has joined the ranks of big pharma companies bolting on RNA-based technology platforms in the wake of Share XAstraZeneca makes a big RNA play, teaming up with VaxEquityhttps://pharmaphorum.com/news/astrazeneca-makes-a-big-rna-play-teaming-up-with-vaxequity/
Magic mushroom compound matches antidepressant in clinical trialThe active compound in magic mushrooms – psilocybin – seems to be at least as effective as a Share XMagic mushroom compound matches antidepressant in clinical trialhttps://pharmaphorum.com/news/magic-mushroom-compound-matches-antidepressant-in-clinical-trial/
UK’s Salient Bio launches robotic COVID-19 testing platformUK diagnostics firm Salient Bio has launched a robotics-driven COVID-19 mass testing platform after spinning out from Imperial Share XUK’s Salient Bio launches robotic COVID-19 testing platformhttps://pharmaphorum.com/news/uks-salient-launches-robotic-covid-19-testing-platform/
Trial starts with Imperial College London coronavirus vaccineThe first healthy volunteer has been dosed with Imperial College London’s coronavirus vaccine, the second UK-developed candidate to Share XTrial starts with Imperial College London coronavirus vaccinehttps://pharmaphorum.com/news/trial-starts-with-imperial-college-london-coronavirus-vaccine/
UK’s Imperial College begins trial of coronavirus vaccineResearchers from Imperial College London have begun clinical trials of a new coronavirus vaccine, backed by funding from the Share XUK’s Imperial College begins trial of coronavirus vaccinehttps://pharmaphorum.com/news/uks-imperial-college-begins-trial-of-coronavirus-vaccine/
